MarketInOut Stock Screener Log In | Sign Up

Mercury Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Mercury Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization877.26 mln
Float0.17 mln

EPS

34.69
Exceptional

P / E

21.62
Premium valuation

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.59
Likely reliable

Relative Strength

60 / 100
Outperforming

Debt / Equity

0.15
Very low leverage

Business Description

Founded in 1962 and based in Vadodara, India, Mercury Laboratories Limited makes and sells a wide range of medicines focused on the health of mothers and children. Its products cover many treatment areas, including pain relief, infection, diabetes, heart health, and women's reproductive health, available in forms such as tablets, liquids, injections, and eye drops. The company also exports its medicines to around 25 countries across Asia, Africa, Latin America, and beyond.

Key Fundamentals

EPS34.69
P/E21.62
ROE7.46
RPS615
ROIC5.36
ROA5.46
Interest Cover8.74
EBITDA, mln93.10
EV / EBITDA10.05
EV / EBIT15.59
Revenue, mln738
EV / Revenue1.27

Quote Details

Last 749.95
Change 15.85 (2.16%)
Open 735.00
Volume 65
Turnover 48,747
Average Volume 64.57

Financial Ratios

Pre-Tax Profit Margin7
Current Ratio3.85
Price / Book1.55
Price / Tangible Book1.55
Price / Free Cash Flow137
Debt / Equity0.15
Price / Sales1.22
PEG Ratio67.57

Financial Strength

Altman Z-Score4.44
Piotroski F-Score 5 / 9
Beneish M-Score-2.59
Price to Intrinsic Value1.55
Price to Graham Number1.10
Shiller PE Ratio19.56

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.13% 77 / 100   
1 Month -8.32% 44 / 100   
2 Months -8.59% 47 / 100   
6 Months -7.12% 50 / 100   
1 Year -9.81% 61 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog